Hello, Fool! | Login | Signup | My Fool
Dec 5, 2008 9:08 AM ET | Feedback | Site Changes | Help
A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.
View All Commentary (IDIX)
Recs
tenmiles (99.99) Submitted: 1/09/08 12:40 PM : Start Price: $3.24 IDIX Score: -100.69
Forget Novartis, use today's strength to short Idenix at $3.25; techncially well overbought - looking for 15% pullback within two quarters.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.